These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 32902341)

  • 1. A Nordic-Baltic perspective on indications for proton therapy with strategies for identification of proper patients.
    Brandal P; Bergfeldt K; Aggerholm-Pedersen N; Bäckström G; Kerna I; Gubanski M; Björnlinger K; Evensen ME; Kuddu M; Pettersson E; Brydøy M; Hellebust TP; Dale E; Valdman A; Weber L; Høyer M
    Acta Oncol; 2020 Oct; 59(10):1157-1163. PubMed ID: 32902341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RBE for proton radiation therapy - a Nordic view in the international perspective.
    Toma-Dasu I; Dasu A; Vestergaard A; Witt Nyström P; Nyström H
    Acta Oncol; 2020 Oct; 59(10):1151-1156. PubMed ID: 33000988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton therapy in the clinic.
    DeLaney TF
    Front Radiat Ther Oncol; 2011; 43():465-485. PubMed ID: 21625169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical controversies: proton radiation therapy for brain and skull base tumors.
    Combs SE; Laperriere N; Brada M
    Semin Radiat Oncol; 2013 Apr; 23(2):120-6. PubMed ID: 23473689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton beams to replace photon beams in radical dose treatments.
    Suit H; Goldberg S; Niemierko A; Trofimov A; Adams J; Paganetti H; Chen GT; Bortfeld T; Rosenthal S; Loeffler J; Delaney T
    Acta Oncol; 2003; 42(8):800-8. PubMed ID: 14968940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton Therapy.
    LaRiviere MJ; Santos PMG; Hill-Kayser CE; Metz JM
    Hematol Oncol Clin North Am; 2019 Dec; 33(6):989-1009. PubMed ID: 31668216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging issues specific to hadrontherapy (proton, carbon, helium therapy and other charged particles) for radiotherapy planning, setup, dose monitoring and tissue response assessment.
    Thariat J; Hérault J; Beddok A; Feuvret L; Dauvergne D; Gérard M; Balosso J; Noël G; Valable S
    Cancer Radiother; 2020 Aug; 24(5):429-436. PubMed ID: 32247687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the NTCP modeling on medical decision to select eligible patient for proton therapy: the usefulness of EUD as an indicator to rank modern photon vs proton treatment plans.
    Chaikh A; Calugaru V; Bondiau PY; Thariat J; Balosso J
    Int J Radiat Biol; 2018 Sep; 94(9):789-797. PubMed ID: 29878849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No.
    Suit H; Kooy H; Trofimov A; Farr J; Munzenrider J; DeLaney T; Loeffler J; Clasie B; Safai S; Paganetti H
    Radiother Oncol; 2008 Feb; 86(2):148-53. PubMed ID: 18237800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of proton beam availability on patient treatment schedule in radiation oncology.
    Miller ED; Derenchuk V; Das IJ; Johnstone PA
    J Appl Clin Med Phys; 2012 Nov; 13(6):3968. PubMed ID: 23149788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Quantitative Clinical Decision-Support Strategy Identifying Which Patients With Oropharyngeal Head and Neck Cancer May Benefit the Most From Proton Radiation Therapy.
    Brodin NP; Kabarriti R; Pankuch M; Schechter CB; Gondi V; Kalnicki S; Guha C; Garg MK; Tomé WA
    Int J Radiat Oncol Biol Phys; 2019 Jul; 104(3):540-552. PubMed ID: 30496877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-modality applicability of rectal normal tissue complication probability models from photon- to proton-based radiotherapy.
    Pedersen J; Flampouri S; Bryant C; Liang X; Mendenhall N; Li Z; Liu M; Muren LP
    Radiother Oncol; 2020 Jan; 142():253-260. PubMed ID: 31630864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of critical structure dose and toxicity risks in patients with low grade gliomas treated with IMRT versus proton radiation therapy.
    Dennis ER; Bussiere MR; Niemierko A; Lu MW; Fullerton BC; Loeffler JS; Shih HA
    Technol Cancer Res Treat; 2013 Feb; 12(1):1-9. PubMed ID: 22775339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton therapy: clinical gains through current and future treatment programs.
    Mohan R; Bortfeld T
    Front Radiat Ther Oncol; 2011; 43():440-464. PubMed ID: 21625168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controversies in clinical trials in proton radiotherapy: the present and the future.
    Miller RC; Lodge M; Murad MH; Jones B
    Semin Radiat Oncol; 2013 Apr; 23(2):127-33. PubMed ID: 23473690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Coming technical advances in radiation oncology].
    Suit H
    Z Med Phys; 2005; 15(4):215-27. PubMed ID: 16422350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Proton therapy in France in 2019].
    Dendale R; Thariat J; Doyen J; Balosso J; Stefan D; Bolle S; Feuvret L; Poortmans P; Hannoun-Lévi JM; Bondiau PY; Micaud M; Alapetite C; Calugaru V; Habrand JL; Mahé MA
    Cancer Radiother; 2019 Oct; 23(6-7):617-624. PubMed ID: 31477441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NTCP reduction for advanced head and neck cancer patients using proton therapy for complete or sequential boost treatment versus photon therapy.
    Jakobi A; Stützer K; Bandurska-Luque A; Löck S; Haase R; Wack LJ; Mönnich D; Thorwarth D; Perez D; Lühr A; Zips D; Krause M; Baumann M; Perrin R; Richter C
    Acta Oncol; 2015; 54(9):1658-64. PubMed ID: 26340301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inclusion of a variable RBE into proton and photon plan comparison for various fractionation schedules in prostate radiation therapy.
    Ödén J; Eriksson K; Toma-Dasu I
    Med Phys; 2017 Mar; 44(3):810-822. PubMed ID: 28107554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protons vs Photons for Brain and Skull Base Tumors.
    Ahmed SK; Brown PD; Foote RL
    Semin Radiat Oncol; 2018 Apr; 28(2):97-107. PubMed ID: 29735196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.